Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Number of shares of common stock	Common stock and additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss
Beginning Balance (in shares) at Dec. 31, 2020		578.3
Balance as of beginning of period at Dec. 31, 2020	$ 9,409		$ 31,802	$ (21,408)	$ (985)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income for basic and diluted EPS	1,646			1,646
Other comprehensive income, net of taxes	152				152
Dividends declared on common stock	(1,012)			(1,012)
Issuance of common stock in connection with the Company’s equity award programs (in shares)		0.7
Issuance of common stock in connection with the Company’s equity award programs	6		6
Stock-based compensation expense	57		57
Tax impact related to employee stock-based compensation expense	(59)		(59)
Repurchases of common stock (in shares)		(3.7)
Repurchases of common stock	(865)			(865)
Ending Balance (in shares) at Mar. 31, 2021		575.3
Balance as of end of period at Mar. 31, 2021	9,334		31,806	(21,639)	(833)
Beginning Balance (in shares) at Dec. 31, 2020		578.3
Balance as of beginning of period at Dec. 31, 2020	9,409		31,802	(21,408)	(985)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income for basic and diluted EPS	3,994
Ending Balance (in shares) at Sep. 30, 2021		565.0
Balance as of end of period at Sep. 30, 2021	8,217		31,989	(22,964)	(808)
Beginning Balance (in shares) at Mar. 31, 2021		575.3
Balance as of beginning of period at Mar. 31, 2021	9,334		31,806	(21,639)	(833)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income for basic and diluted EPS	464			464
Other comprehensive income, net of taxes	(35)				(35)
Issuance of common stock in connection with the Company’s equity award programs (in shares)		0.8
Issuance of common stock in connection with the Company’s equity award programs	47		47
Stock-based compensation expense	100		100
Tax impact related to employee stock-based compensation expense	(76)		(76)
Repurchases of common stock (in shares)		(6.5)
Repurchases of common stock	(1,592)			(1,592)
Other	5			5
Ending Balance (in shares) at Jun. 30, 2021		569.6
Balance as of end of period at Jun. 30, 2021	8,247		31,877	(22,762)	(868)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income for basic and diluted EPS	1,884			1,884
Other comprehensive income, net of taxes	60				60
Dividends declared on common stock	(1,017)			(1,017)
Issuance of common stock in connection with the Company’s equity award programs (in shares)		0.0
Issuance of common stock in connection with the Company’s equity award programs	9		9
Stock-based compensation expense	111		111
Tax impact related to employee stock-based compensation expense	(8)		(8)
Repurchases of common stock (in shares)		(4.6)
Repurchases of common stock	(1,069)			(1,069)
Ending Balance (in shares) at Sep. 30, 2021		565.0
Balance as of end of period at Sep. 30, 2021	$ 8,217		31,989	(22,964)	(808)
Beginning Balance (in shares) at Dec. 31, 2021	558.3	558.3
Balance as of beginning of period at Dec. 31, 2021	$ 6,700		32,096	(24,600)	(796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income for basic and diluted EPS	1,476			1,476
Other comprehensive income, net of taxes	33				33
Dividends declared on common stock	(1,034)			(1,034)
Issuance of common stock in connection with the Company’s equity award programs (in shares)		0.5
Issuance of common stock in connection with the Company’s equity award programs	18		18
Stock-based compensation expense	78		78
Tax impact related to employee stock-based compensation expense	(45)		(45)
Repurchases of common stock (in shares)		(24.6)
Repurchases of common stock	(6,310)		(900)	(5,410)
Ending Balance (in shares) at Mar. 31, 2022		534.2
Balance as of end of period at Mar. 31, 2022	$ 916		31,247	(29,568)	(763)
Beginning Balance (in shares) at Dec. 31, 2021	558.3	558.3
Balance as of beginning of period at Dec. 31, 2021	$ 6,700		32,096	(24,600)	(796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income for basic and diluted EPS	$ 4,936
Ending Balance (in shares) at Sep. 30, 2022	533.5	533.5
Balance as of end of period at Sep. 30, 2022	$ 3,653		32,371	(28,066)	(652)
Beginning Balance (in shares) at Mar. 31, 2022		534.2
Balance as of beginning of period at Mar. 31, 2022	916		31,247	(29,568)	(763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income for basic and diluted EPS	1,317			1,317
Other comprehensive income, net of taxes	91				91
Issuance of common stock in connection with the Company’s equity award programs (in shares)		0.7
Issuance of common stock in connection with the Company’s equity award programs	45		45
Stock-based compensation expense	120		120
Tax impact related to employee stock-based compensation expense	(69)		(69)
Other	(1)			(1)
Ending Balance (in shares) at Jun. 30, 2022		534.9
Balance as of end of period at Jun. 30, 2022	2,419		31,343	(28,252)	(672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income for basic and diluted EPS	2,143			2,143
Other comprehensive income, net of taxes	20				20
Dividends declared on common stock	(1,057)			(1,057)
Issuance of common stock in connection with the Company’s equity award programs (in shares)		0.1
Issuance of common stock in connection with the Company’s equity award programs	15		15
Stock-based compensation expense	121		121
Tax impact related to employee stock-based compensation expense	(8)		(8)
Repurchases of common stock (in shares)		(1.5)
Repurchases of common stock	$ 0		900	(900)
Ending Balance (in shares) at Sep. 30, 2022	533.5	533.5
Balance as of end of period at Sep. 30, 2022	$ 3,653		$ 32,371	$ (28,066)	$ (652)